UPDATE: Raymond James Downgrades Nutanix (NTNX) to Market Perform
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Nutanix (NTNX) PT Lowered to $45 at FBN Securities
March 1, 2019 11:41 AM ESTFBN Securities analyst Shebly Seyrafi lowered the price target on Nutanix (NASDAQ: NTNX) to $45.00 (from $70.00) while maintaining a Outperform rating.
Analyst says: "NTNX recently introduced many products such as products in its Nutanix Essentials offering (Files, Flow, Calm, and Prism) and Nutanix Enterprise (Era for database automation, Karbon for Kubernetes management, Volumes for scale-out storage, Buckets for S3-compatible object storage), Leap for disaster recovery, Xi Frame for running desktops in the browser, Xi Epoch for monitoring multi-cloud applications, Xi Beam (multi-cloud optimization service, and Xi IoT for secure edge intelligence for... More
Pre-Open Stock Movers 03/01: (PBYI) (GPS) (ZS) Higher; (IMGN) (NTNX) (TSLA) Lower (more...)
March 1, 2019 9:23 AM ESTPre-Open Movers
ImmunoGen, Inc., (Nasdaq: IMGN) 48.9% LOWER; announced that its Phase 3 FORWARD I trial evaluating the safety and efficacy of mirvetuximab soravtansine compared to chemotherapy in patients with folate receptor alpha... More
Nutanix (NTNX) PT Lowered to $48 at Raymond James
March 1, 2019 7:37 AM ESTRaymond James analyst Simon Leopold lowered the price target on Nutanix (NASDAQ: NTNX) to $48.00 (from $53.00) while maintaining a Outperform rating.
... MoreNutanix (NTNX) PT Lowered to $53 at Morgan Stanley
March 1, 2019 7:36 AM ESTMorgan Stanley analyst Katy Huberty lowered the price target on Nutanix (NASDAQ: NTNX) to $53.00 (from $58.00) while maintaining a Overweight rating.
... MoreNutanix (NTNX) PT Lowered to $63 at Needham & Company
March 1, 2019 7:17 AM ESTNeedham & Company analyst Jack Andrews lowered the price target on Nutanix (NASDAQ: NTNX) to $63.00 (from $76.00) while maintaining a Buy rating.
... MoreNutanix (NTNX) PT Lowered to $52 at RBC Capital; Long-Term Thesis Unchanged
March 1, 2019 7:10 AM ESTRBC Capital analyst Matthew Hedberg lowered the price target on Nutanix (NASDAQ: NTNX) to $52.00 (from $64.00) while maintaining a Outperform rating following disappointing results.
Hedberg commented, "Guidance moves lower as management noted inadequate marketing spend for pipeline generation and slower-than-expected sales hiring. The... More
UPDATE: Oppenheimer Downgrades Nutanix (NTNX) to Perform
March 1, 2019 5:37 AM EST(Updated - March 1, 2019 9:25 AM EST)
(updated to add analyst comments)
Oppenheimer analyst Ittai Kidron downgraded Nutanix (NASDAQ: NTNX) from Outperform to Perform.
The analyst commented, "Nutanix reported a mixed quarter with some positives (record $1M deal sizes, 40% AHV adoption, multiple Enterprise/Essentials... More
Wells Fargo Downgrades Nutanix (NTNX) to Market Perform
March 1, 2019 3:35 AM ESTWells Fargo downgraded Nutanix (NASDAQ: NTNX) from Outperform to Market Perform with a price target of $45.00 (from $70.00).
"While Nutanix is a leader in the fast growing hyper-converged infrastructure (HCI) market, we remain cautious on near term sales execution as the company looks... MoreStifel Downgrades Nutanix (NTNX) to Hold
March 1, 2019 3:27 AM ESTStifel analyst Brad Reback downgraded Nutanix (NASDAQ: NTNX) from Buy to Hold with a price target of $39.00 (from $55.00).
Says guidance fell "woefully short" of consensus estimates.Notes software/support revenue target is in high-teens now compared with 40% (and as high as... MoreNutanix (NTNX) PT Lowered to $52 at JMP Securities
March 1, 2019 3:20 AM ESTJMP Securities lowered its price target on Nutanix (NASDAQ: NTNX) to $52.00 (from $60.00) while maintaining a Market Outperform rating.
... MoreAfter-Hours Movers 02/28: (GPS) (PBYI) (FNKO) Higher; (MRSN) (NTNX) (TSLA) (more...)
February 28, 2019 5:58 PM ESTAfter-Hours Movers
Gap Inc. (NYSE: GPS) 26.9% HIGHER; announced plans to create two independent publicly traded companies: Old Navy, a category-leader in family apparel, and a yet-to-be-named company (NewCo), which will consist of the iconic Gap brand, Athleta, Banana Republic, Intermix and Hill City. Gap Inc. expects to effect the separation through a spin-off that is intended to generally be tax-free to Gap Inc.s shareholders for U.S. federal income tax purposes. The spin-off will enable each company to maximize focus and flexibility, align investments and incentives to meet its... More
Nutanix (NTNX) Tops Q2 EPS by 2c; Guides Below
February 28, 2019 4:06 PM ESTNutanix (NASDAQ: NTNX) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $335.4 million versus the consensus estimate of $331.3 million.
Our product portfolio is coming together really well as we double down on simplicity and reliability. On a trailing four... More